Liquid Biopsy Assay for early cancer detection
4D Lifetec AG is the pioneering company in non-genomic, immuno-oncologic blood assays for early cancer diagnostic. Due to its proprietary transformational DDS biomarker, 4D Lifetest™ has several possibilities to expand its market activities, become a key element in the diagnostic cascade for other major cancer types and support genomic liquid biopsy methods by adding high early detection sensitivity (> 90% at Stage I). 4D Lifetest™ Lung Dx is the company’s flagship product which is marketed with an initial focus on early lung cancer diagnostic. Additional applications (4D Lifetest™ Breast Dx, 4D Lifetest™ Prostate Dx, 4D Lifetest™ Colon Dx) are already CE IVD certified and ready to access the markets.
4D Lifetec participated in the Venture Leaders Biotech program in 2019.
